Anastasios Apostolos, Nikolaos Ktenopoulos, Dimitrios-David Chlorogiannis, Odysseas Katsaros, Konstantinos Konstantinou, Maria Drakopoulou, Sotirios Tsalamandris, Antonios Karanasos, Andreas Synetos, Georgios Latsios, Constantina Aggeli, Vasileios Panoulas, Costas Tsioufis, Konstantinos Toutouzas
Patients with severe aortic stenosis (AoS) often present with acute heart failure and compensation, frequently leading to cardiogenic shock. Transcatheter Aortic Valve Replacement (TAVR) has been recently performed as a bailout treatment in such patients. The aim of our meta-analysis is to compare urgent TAVR with elective procedures. We systematically screened three databases searching for studies comparing urgent vs elective TAVR. Primary endpoint is the 30-days mortality. Secondary endpoints included in-hospital mortality, device success, periprocedural vascular complications, 30-days stroke, 30-days acute kidney injury (AKI), permanent pacemaker implantation (PPM), moderate or severe paravalvular leakage, and 30-days bleeding...
April 13, 2024: Angiology